Eli Lilly And Co (LLY) is near the top in its industry group according to InvestorsObserver. LLY gets an overall rating of 64. That means it scores higher than 64 percent of stocks. Eli Lilly And Co gets a 61 rank in the Drug Manufacturers - General industry. Drug Manufacturers - General is number 7 out of 148 industries.
What do These Ratings Mean?
Finding the best stocks can be tricky. It isn’t easy to compare companies across industries. Even companies that have relatively similar businesses can be tricky to compare sometimes. InvestorsObserver’s tools allow a top-down approach that lets you pick a metric, find the top sector and industry and then find the top stocks in that sector.
These scores are not only easy to understand, but it is easy to compare stocks to each other. You can find the best stock in an industry, or look for the sector that has the highest average score. The overall score is a combination of technical and fundamental factors that serves as a good starting point when analyzing a stock. Traders and investors with different goals may have different goals and will want to consider other factors than just the headline number before making any investment decisions.
What's Happening With Eli Lilly And Co Stock Today?
Eli Lilly And Co (LLY) stock is lower by -0.33% while the S&P 500 is higher by 0.55% as of 3:04 PM on Wednesday, Feb 19. LLY is down -$0.46 from the previous closing price of $141.01 on volume of 1,761,842 shares. Over the past year the S&P 500 has gained 21.91% while LLY is higher by 15.08%. LLY earned $4.96 a per share in the over the last 12 months, giving it a price-to-earnings ratio of 28.36.
To see the top 5 stocks in Drug Manufacturers - General click here.
